You are here
Following the completion of the 2016 Inter-Rater Reliability (IRR) study to test the consistency of clinician application of the mental health phase of care, the poor to fair reliability outcome led to the commencement of the refinement project.
The Independent Hospital Pricing Authority (IHPA) has developed the Australian Mental Health Care Classification Pricing Feasibility Report 2020–21 to provide an overview of the process undertaken by IHPA to shadow price admitted mental health services using the Australian Mental Health Care Classification (AMHCC) Version 1.0.
This document provides background to the development of the new classification, explains the data elements and collection protocols, reporting requirements, and how the data is grouped.
The Australian Hospital Patient Costing Standards (AHPCS) provide direction for hospital patient costing through the development of standards for specific elements of the costing process and reporting requirements.
The AHPCS Version 4.0 was developed through extensive consultation with jurisdictions and stakeholders. The AHPCS Version 4.0 comprises:
The Inter-rater reliability study final report was approved by the Pricing Authority in April 2017. The primary aims of the study were to test the inter-rater reliability of the mental health phase of care instrument, gather information about the clinicians' views of the mental health phase of care, identifying ways of increasing the clarity to reduce the ambiguity of the instrument, and to provide recommendations on how the instrument may be refined.
This document provides information for clinicians to enable them to assess phases accurately when applying the new concept of mental health phase of care.
This document describes the Australian Mental Health Care Classification and the process IHPA has undertaken to develop the new classification.
The Independent Hospital Pricing Authority is committed to providing the Australian health care industry with a nationally consistent method of classifying all types of patients, their treatment and associated costs. Consequently, resources continue to be devoted to the ongoing development of a Diagnosis Related Groups (DRG) classification system based on local clinical practice.
This report presents the results of phase one of the project to develop Australian Refined Diagnosis Related Groups (AR-DRG)1 Version (V) 8.0. This phase focuses on the case complexity component of the classification that has not been reviewed for many years
IHPA has developed a robust set of standard costs for the revised List of standard items associated with conducting clinical trials in Australia.
IHPA values the feedback it receives from jurisdictions, peak bodies, other interested stakeholder groups, and the community as it progresses work to develop and refine the Australian Mental Health Care Classification (AMHCC) and its supporting material, both in the immediate future and the longer term.